Ionis Pharmaceuticals (IONS) Asset Utilization Ratio (2010 - 2026)
Ionis Pharmaceuticals (IONS) posted quarterly Asset Utilization Ratio of 0.21 for Q2 2026, down 35.39% year-over-year from 0.33 in Q2 2025, and down 14.9% quarter-over-quarter from 0.25 in Q1 2026.
Ionis Pharmaceuticals (IONS) Asset Utilization Ratio (2010 - 2026) Analysis & Trends
Ionis Pharmaceuticals' Asset Utilization Ratio history runs 17 years deep, the most recent figure standing at 0.21 for Q2 2026.
- In Q2 2026, Asset Utilization Ratio fell 35.39% year-over-year to 0.21; the TTM figure through Jun 2026 stood at 0.21 (down 35.39% YoY), while the FY2025 annual figure was 0.29, up 22.89% from the prior year.
- Asset Utilization Ratio for Q2 2026 stood at 0.21, down from 0.25 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.36 in Q3 2022, with the low at 0.21 in Q3 2023.
- The 5-year median for Asset Utilization Ratio is 0.27 (2023), against an average of 0.27.
- The sharpest annual moves came in 2022 and 2023: Asset Utilization Ratio soared 133.23% in 2022, then slumped 41.97% in 2023.
- Ionis Pharmaceuticals' Asset Utilization Ratio stood at 0.24 in 2022, then increased by 12.18% to 0.27 in 2023, then declined by 12.84% to 0.23 in 2024, then advanced by 24.2% to 0.29 in 2025, then decreased by 26.9% to 0.21 in 2026.
- Business Quant data shows IONS's Asset Utilization Ratio at 0.21 in Q2 2026, 0.25 in Q1 2026, and 0.29 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.69 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 186.67 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.13 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.90 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.54 |
| 10 | Ionis Pharmaceuticals | 9.48 Bn | 7.43 Bn | 265.21 Mn | 0.21 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.21 |
| Mar 31, 2026 | 0.25 |
| Dec 31, 2025 | 0.29 |
| Sep 30, 2025 | 0.32 |
| Jun 30, 2025 | 0.33 |
| Mar 31, 2025 | 0.25 |
| Dec 31, 2024 | 0.23 |
| Sep 30, 2024 | 0.28 |
| Jun 30, 2024 | 0.30 |
| Mar 31, 2024 | 0.27 |
| Dec 31, 2023 | 0.27 |
| Sep 30, 2023 | 0.21 |
| Jun 30, 2023 | 0.22 |
| Mar 31, 2023 | 0.21 |
| Dec 31, 2022 | 0.24 |
| Sep 30, 2022 | 0.36 |
| Jun 30, 2022 | 0.34 |
| Mar 31, 2022 | 0.33 |
| Dec 31, 2021 | 0.32 |
| Sep 30, 2021 | 0.17 |